𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast

✍ Scribed by Gil Facina; Pedro Vitor Lopes-Costa; Alesse Ribeiro Dos Santos; Rodrigo Jose De Vasconcelos-Valença; André Luis Pinho-Sobral; Celso Pires Ferreira-Filho; Airlane Pereira Alencar; Luiz Henrique Gebrim; Benedito Borges Da Silva

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
168 KB
Volume
38
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ductal carcinoma in situ of the breast
Ductal carcinoma in situ of the breast
✍ Harris, Jules E. ;Bruetman, Daniel ;Bloom, Ken ;Bines, Steven 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB
Ductal carcinoma in situ of the male bre
Ductal carcinoma in situ of the male breast
✍ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

Aberrant expression of muc1 mucin in duc
Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast
✍ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought

Heterogeneity of ductal carcinoma in sit
Heterogeneity of ductal carcinoma in situ of the breast
✍ Michael D. Lagios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents

Thoughts about ductal carcinoma in situ
Thoughts about ductal carcinoma in situ of the breast
✍ Lawrence, Walter 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering